Press Releases

XORTX Initiates Dosing of Human Subjects in the XRX-OXY-101 Clinical Trial

XORTX Receives Small and Medium Enterprise Status for the European Union

XORTX Receives No Objection Letter from Health Canada

XORTX Announces Grant of US Patent

XORTX Files IND with US FDA

XORTX Files New PCT Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection

XORTX Therapeutics Announces Submission of Clinical Trial Application to Conduct Bridging Pharmacokinetics Study

XORTX Provides Corporate Update

XORTX Announces Appointment of Chief Technology Officer

XORTX to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference